Florez Helena, Peris Pilar, Guañabens Núria
Servicio de Reumatología, Hospital Clínic, Universidad de Barcelona, Barcelona, España.
Servicio de Reumatología, Hospital Clínic, Universidad de Barcelona, Barcelona, España.
Med Clin (Barc). 2016 Dec 16;147(12):547-553. doi: 10.1016/j.medcli.2016.07.030. Epub 2016 Oct 17.
Fibrous dysplasia is a skeletal disorder that is associated with a wide spectrum of clinical manifestations, including localized asymptomatic forms and extensive severe forms with severe bone deformities and endocrinological alterations, depending on age, location, extent and associated processes. Although the treatment of choice is based on bisphosphonates, the therapeutic efficacy of these agents in the control of disease activity remains uncertain. This article reviews the current data available on the treatment of this disease as well as the preliminary data on new therapeutic approaches.
骨纤维异常增殖症是一种骨骼疾病,根据年龄、部位、范围及相关病变的不同,可伴有广泛的临床表现,包括局部无症状型以及伴有严重骨畸形和内分泌改变的广泛严重型。尽管治疗的首选药物是双膦酸盐,但这些药物在控制疾病活动方面的治疗效果仍不确定。本文综述了目前关于该疾病治疗的现有数据以及新治疗方法的初步数据。